CNS pipeline · person

Alan Breier, M.D.

Member of the BioXcel Therapeutics Neuroscience Clinical Advisory Board (formed 2018 for BXCL501). Professor of Psychiatry and Vice-Chair for Clinical Research at Indiana University School of Medicine and former Chief Medical Officer at Eli Lilly; research focuses on schizophrenia therapeutics.

0 companies

Past roles

BioXcel Therapeutics, Inc.Neuroscience Clinical Advisory Board Member · Advisor

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.